Institutional Ownership
Xilio Therapeutics Inc
CUSIP 98422T100COMXLOQ1 2026
Insider Transactions
8
Form 4 lines on record
Reporting Insiders
8
Distinct officers & directors
90d Buys
0
Open-market purchase shares
90d Sells
0
Open-market sale shares
Insider Transactions — Form 4
8 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jun 11, 2026 | Curran Daniel J. | Director | A · Grant | 5.0K | — | — | 5.0K | SEC |
| 2 | Jun 11, 2026 | Shannon James Samuel | Director | A · Grant | 5.0K | — | — | 5.0K | SEC |
| 3 | Jun 11, 2026 | Bello Akintunde Olatokumbo | Director | A · Grant | 5.0K | — | — | 5.0K | SEC |
| 4 | Jun 11, 2026 | Xu Yuan | Director | A · Grant | 5.0K | — | — | 5.0K | SEC |
| 5 | Jun 11, 2026 | Ross Robert W. | Director | A · Grant | 5.0K | — | — | 5.0K | SEC |
| 6 | Jun 11, 2026 | Bonstein Sara | Director | A · Grant | 5.0K | — | — | 5.0K | SEC |
| 7 | Jun 11, 2026 | Brennan Aoife | Director | A · Grant | 5.0K | — | — | 5.0K | SEC |
| 8 | Feb 13, 2026 | Gilead Sciences, Inc. | 10% Owner | P · Buy | 3.74M | $0.53 | $2.00M | 40.38M | SEC |